A California jury has sided with Johnson & Johnson in the first trial over whether its iconic baby powder caused a woman to get mesothelioma.

Thursday's verdict came in a trial that began on Oct. 19 in Los Angeles Superior Court. The jury found on Thursday that Johnson & Johnson did not negligently manufacture or design its baby powder and Shower to Shower products or fail to warn that its talcum powder products caused mesothelioma, according to coverage of the trial by Courtroom View Network. The jury also sided with Imerys Talc America Inc., a talc supplier, in its verdict.

Related: Talc, product liability insurance and recent class action lawsuits

Separate from cases alleging ovarian cancer

The trial is separate from the nearly 5,000 cases alleging Johnson & Johnson's talcum powder products caused women to get ovarian cancer. In those cases, juries in Missouri and California have come out with five verdicts ranging from $55 million to $417 million — though two awards have since been tossed out. Unlike those cases, which have focused on the alleged links between Johnson & Johnson's talc products and ovarian cancer, the mesothelioma cases target whether cosmetic talc products contained asbestos, which is known to cause mesothelioma.

Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader

  • All PropertyCasualty360.com news coverage, best practices, and in-depth analysis.
  • Educational webcasts, resources from industry leaders, and informative newsletters.
  • Other award-winning websites including BenefitsPRO.com and ThinkAdvisor.com.

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Amanda Bronstad

Amanda Bronstad is the ALM staff reporter covering class actions and mass torts nationwide. She writes the email dispatch Law.com Class Actions: Critical Mass. She is based in Los Angeles.